{"id":8693,"date":"2020-07-27T09:13:47","date_gmt":"2020-07-27T14:13:47","guid":{"rendered":"https:\/\/saluddigital.com\/?p=8693"},"modified":"2025-10-21T14:40:02","modified_gmt":"2025-10-21T20:40:02","slug":"avances-en-inteligencia-artificial-podrian-detectar-cancer-de-pancreas","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/avance-de-la-ciencia\/avances-en-inteligencia-artificial-podrian-detectar-cancer-de-pancreas\/","title":{"rendered":"Advances in Artificial Intelligence could detect pancreatic cancer"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

The progress of Artificial Intelligence (AI) has brought new benefits for health research and early detection of diseases in recent years.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The European Society of Medical Oncology (ESMO) organized the World Congress on Gastrointestinal Cancer, which would take place in early July. However, because of the current health situation in the world it was postponed and will offer virtual days between July 16 and August 27.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

However, this conference will present the progress of a study promising the early detection of pancreatic cancer. Pancreatic cancer is a disease that affects 12 in 100,000 people, meaning that a method of screening through testing would not be efficient. Other cancers may have tests or tests that determine a possible disease, because in some cancers they exist in populations with more risk to develop the disease. By age group or by gender, for example, breast cancer and prostate cancer.<\/p>

For this preliminary study, electronic health records (EHR), used by general practitioners of patients in the UK, were supported. The analysis included 1,378 patients aged 15 to 99 diagnosed with pancreatic cancer between 2005 and 2010. In addition, each patient was paired by age and sex with four other people without a cancer diagnosis.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At that stage is where AI was the most important part, since information on symptoms, diseases, medications in the two years prior to diagnosis and thus develop a model predicting who might develop cancer. The pilot study found that the model can predict which people under the age of 60 were most at risk of getting sick and make a diagnosis more than 20 months before developing the disease.<\/p>

\u201cOur model has estimated that around 1,500 tests need to be performed to save one life from pancreatic cancer\u201d explained Dr. Ananya Malhotra researcher in statistics, London School of Hygiene &Tropical Medicine, London, UK. In addition, he explained that they used AI to study an extensive volume of data and find exact combinations to predict who might develop the disease. He further stated that: \u201cIt\u2019s not possible for the human eye to recognize these trends in such large amounts of data\u201d.<\/p>

In this way, the combination of traditional non-invasive techniques and modern Digital Health techniques such as Artificial Intelligence or EHR can achieve a more than positive result for early diagnosis of diseases where time is a key factor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tBIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

ISMO<\/strong><\/p>

https:\/\/www.esmo.org\/newsroom\/press-office\/artificial-intelligence-pancreatic-cancer-screening-reality<\/a><\/p>

\u00a0<\/p>

AZOROBOTICS<\/strong><\/p>

https:\/\/www.azorobotics.com\/News.aspx?newsID=11429<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

El avance de la Inteligencia Artificial (IA), ha tra\u00eddo en los \u00faltimos a\u00f1os nuevos beneficios para la investigaci\u00f3n en salud y la detecci\u00f3n temprana de enfermedades. La Sociedad Europea de Oncolog\u00eda M\u00e9dica, (ESMO, por sus siglas en ingl\u00e9s), organiz\u00f3 el congreso Mundial sobre C\u00e1ncer Gastrointestinal, que se llevar\u00eda a cabo a inicios de julio. Sin embargo, por la situaci\u00f3n sanitaria actual en el mundo fue postergado y ofrecer\u00e1 jornadas virtuales entre el 16 de julio y 27 de agosto. No obstante, en este congreso ser\u00e1 presentado el avance de un estudio que promete la detecci\u00f3n temprana de c\u00e1ncer de p\u00e1ncreas. El c\u00e1ncer pancre\u00e1tico es una enfermedad que afecta a 12 de 100 mil personas, lo que significa que un m\u00e9todo de vigilancia a trav\u00e9s de pruebas no ser\u00eda eficiente. En otros tipos de c\u00e1ncer es posible realizar ex\u00e1menes o pruebas que determinen una posible enfermedad, esto porque en algunos tipos de c\u00e1ncer existen en poblaciones m\u00e1s propensas a desarrollar la enfermedad. Por grupos de edad o por sexo, por ejemplo, el c\u00e1ncer de seno y el c\u00e1ncer de pr\u00f3stata. Para la realizaci\u00f3n de este estudio preliminar, se apoyaron los expedientes cl\u00ednicos electr\u00f3nicos (ECE), utilizados por los m\u00e9dicos generales de los pacientes en el Reino Unido. El an\u00e1lisis incluy\u00f3 a 1,378 pacientes entre 15 y 99 a\u00f1os diagnosticados con c\u00e1ncer de p\u00e1ncreas entre 2005 y 2010. Adem\u00e1s, cada paciente fue emparejado por edad y sexo con otras cuatro personas sin diagn\u00f3stico de c\u00e1ncer. En esa etapa es donde la IA fue la parte m\u00e1s importante, ya que la informaci\u00f3n sobre s\u00edntomas, enfermedades, medicaciones en los dos a\u00f1os anteriores al diagn\u00f3stico y de esta manera desarrollar un modelo prediciendo qui\u00e9n podr\u00eda desarrollar c\u00e1ncer. El estudio piloto encontr\u00f3 que el modelo puede predecir qu\u00e9 personas menores de 60 a\u00f1os ten\u00edan mayor riesgo de enfermar y realizar un diagn\u00f3stico m\u00e1s de 20 meses antes de desarrollar la enfermedad. \u201cNuestro modelo estima que se necesitan realizar alrededor de 1.500 test para salvar una vida de c\u00e1ncer de p\u00e1ncreas\u201d explic\u00f3 la Dra. Ananya Malhotra, investigadora encargada de estad\u00edstica en la investigaci\u00f3n, perteneciente a la London School of Hygiene &Tropical Medicine. Adem\u00e1s, explic\u00f3 que utilizaron la IA para estudiar un extenso volumen de datos y encontrar combinaciones exactas para predecir qui\u00e9n podr\u00eda desarrollar la enfermedad. Asegur\u00f3 adem\u00e1s que: “No es posible para el ojo humano reconocer tendencias en grandes cantidades de datos como esta”. De esta manera, la combinaci\u00f3n de t\u00e9cnicas tradicionales no invasivas y t\u00e9cnicas modernas de Salud Digital como la Inteligencia Artificial o el ECE, pueden lograr un resultado m\u00e1s que positivo para el diagn\u00f3stico temprano de enfermedades en las que el tiempo es un factor clave. BIBLIOGRAF\u00cdA ESMO https:\/\/www.esmo.org\/newsroom\/press-office\/artificial-intelligence-pancreatic-cancer-screening-reality \u00a0 AZOROBOTICS https:\/\/www.azorobotics.com\/News.aspx?newsID=11429<\/p>","protected":false},"author":1,"featured_media":8694,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[152,156],"tags":[145],"class_list":["post-8693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-avance-de-la-ciencia","category-big-data","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/8693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=8693"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/8693\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media\/8694"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=8693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=8693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=8693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}